IntegraGen
ALINT | PA
Overview
Corporate Details
- ISIN(s):
- FR0010908723
- LEI:
- 969500CQD8K0BUIGDH55
- Country:
- France
- Address:
- 5 RUE HENRI DESBRUERES, 91000 EVRY-COURCOURONNES
- Website:
- https://integragen.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
IntegraGen is an OncoDNA Group company specializing in the genomics of cancer and genetic diseases. Backed by highly competent and qualified teams, IntegraGen is a leading player in genomic services which has been operating sequencing platforms for research institutes of excellence. IntegraGen's mission is to translate molecular research into clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries. The company also strives to be a leader in providing cutting-edge genomic services to academic researchers and life sciences companies based on the company's technological expertise and scientific know-how.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-04-29 18:00 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 351.8 KB | |
| 2025-04-29 18:00 |
Earnings Release
Inside Information / News release on accounts, results
|
English | 356.4 KB | |
| 2025-01-15 18:44 |
Earnings Release
Inside Information / Information on annual revenues
|
English | 214.4 KB | |
| 2025-01-15 18:44 |
Earnings Release
Informations privilégiées / Information sur chiffre d’affaires annuel
|
French | 215.6 KB | |
| 2024-10-17 18:29 |
Earnings Release
Inside Information / News release on accounts, results
|
English | 343.2 KB | |
| 2024-10-17 18:29 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 398.7 KB | |
| 2024-07-18 18:44 |
Earnings Release
Inside Information / Other news releases
|
English | 270.7 KB | |
| 2024-07-18 18:44 |
Earnings Release
Informations privilégiées / Autres communiqués
|
French | 268.3 KB | |
| 2024-04-18 18:00 |
Earnings Release
Inside Information / News release on accounts, results
|
English | 372.7 KB | |
| 2024-04-18 18:00 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 419.4 KB | |
| 2024-01-16 17:45 |
Earnings Release
Inside Information / Information on annual revenues
|
English | 307.9 KB | |
| 2024-01-16 17:45 |
Earnings Release
Informations privilégiées / Information sur chiffre d’affaires annuel
|
French | 269.3 KB | |
| 2023-10-19 18:15 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 332.6 KB | |
| 2023-07-13 07:30 |
Inside Information Statement
Inside Information / Other news releases
|
English | 204.7 KB | |
| 2023-04-24 18:00 |
Inside Information Statement
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 330.5 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
OSE Immunotherapeutics | France | OSE | |
|
Ovoca Bio Plc | Ireland | OVXA | |
|
Oxford Biomedica PLC | United Kingdom | OXB | |
|
OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC | United Kingdom | OCTHF | |
|
Oxurion NV | Belgium | OXUR | |
|
PCI Biotech Holding | Norway | PCIB | |
|
Pentixapharm Holding AG | Germany | PTP | |
|
Perpetua Medical AB | Sweden | PERP | |
|
PharmaLundensis AB | Sweden | PHAL | |
|
Pharma Mar S.A. | Spain | PHM |